Benzocaine (topical): Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
m (Protected "Benzocaine (topical)": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(8 intermediate revisions by 2 users not shown)
Line 5: Line 5:
|drugClass=[[local anesthetic]]
|drugClass=[[local anesthetic]]
|indicationType=treatment
|indicationType=treatment
|indication=dental pain
|indication=[[dental pain]]
|adverseReactions=contact dermatitis
|adverseReactions=[[contact dermatitis]]
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
* Content


<!--Adult Indications and Dosage-->
<!--Adult Indications and Dosage-->
Line 16: Line 14:
<!--FDA-Labeled Indications and Dosage (Adult)-->
<!--FDA-Labeled Indications and Dosage (Adult)-->
|fdaLIADAdult=* For oral mucosal use only as directed by a dentist.
|fdaLIADAdult=* For oral mucosal use only as directed by a dentist.
 
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
|offLabelAdultGuideSupport=
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


<!--Non–Guideline-Supported Use (Adult)-->
<!--Non–Guideline-Supported Use (Adult)-->
|offLabelAdultNoGuideSupport=
|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


<!--Pediatric Indications and Dosage-->
<!--Pediatric Indications and Dosage-->


<!--FDA-Labeled Indications and Dosage (Pediatric)-->
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
|fdaLIADPed=
|fdaLIADPed=There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.


<!--Off-Label Use and Dosage (Pediatric)-->
<!--Off-Label Use and Dosage (Pediatric)-->


<!--Guideline-Supported Use (Pediatric)-->
<!--Guideline-Supported Use (Pediatric)-->
|offLabelPedGuideSupport=
|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


<!--Non–Guideline-Supported Use (Pediatric)-->
<!--Non–Guideline-Supported Use (Pediatric)-->
|offLabelPedNoGuideSupport=
|offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


<!--Contraindications-->
<!--Contraindications-->
|contraindications=
|contraindications=<!--Warnings-->
<!--Warnings-->
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
|postmarketing=contact dermatitis, methemoglobinemia (rare)
|postmarketing=contact dermatitis, methemoglobinemia (rare)
|drugInteractions=
|drugInteractions=<!--Use in Specific Populations-->
<!--Use in Specific Populations-->
|useInPregnancyFDA=* '''Pregnancy Category'''
|useInPregnancyFDA=* '''Pregnancy Category'''
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
Line 76: Line 62:


<!--Overdosage-->
<!--Overdosage-->
|overdose=
|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
 
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.


<!--Pharmacology-->
<!--Pharmacology-->


<!--Drug box 2-->
<!--Drug box 2-->
|drugBox=<!--Mechanism of Action-->
|drugBox={{drugbox2
|mechAction=
| Watchedfields = changed
| verifiedrevid = 457480862
| IUPAC_name = Ethyl 4-aminobenzoate
| image = Benzocaine.png
| image2 = Benzocaine-from-xtal-3D-balls.png


<!--Structure-->
<!--Clinical data-->
|structure=*
| Drugs.com = {{Drugs.com|monograph|benzocaine-topical}}
| tradename = Anbesol, Cepacol, Lanacane, Orajel
| pregnancy_US = C
| routes_of_administration = Topical
| legal_US = OTC
<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =


: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 94-09-7
| ATC_prefix = C05
| ATC_suffix = AD03
| ATC_supplemental =  {{ATC|D04|AB04}}, {{ATCvet|N01|AX92}}, {{ATC|N01|BA05}}, {{ATC|R02|AD01}}
| PubChem = 2337
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01086
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 13854242
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = U3RSY48JW5
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00552
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 116735
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 278172


<!--Pharmacodynamics-->
<!--Chemical data-->
| C=9 | H=11 | N=1 | O=2
| molecular_weight = 165.189 g/mol
| smiles = O=C(OCC)c1ccc(N)cc1
| InChI = 1/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BLFLLBZGZJTVJG-UHFFFAOYSA-N
}}
|mechAction=<!--Structure-->
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.


Line 105: Line 131:
<!--How Supplied-->
<!--How Supplied-->
|storage=* Store at controlled room temperature 59-86°F (15-30°C).
|storage=* Store at controlled room temperature 59-86°F (15-30°C).
|packLabel=[[File:XXXXX.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]
|packLabel=[[File:Benzocaine 01.jpg|thumb|none|400px|This image is provided by the National Library of Medicine.]]
[[File:XXXXX.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]
[[File:DailyMed TOPICAL ANESTHETIC BANANA benzocaine gel dentifrice.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.


Line 115: Line 141:
|brandNames=* TOPICAL ANESTHETIC BANANA®<ref>{{Cite web | title =TOPICAL ANESTHETIC BANANA- benzocaine gel, dentifrice  | url =http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4fdfcaf-aa95-45a8-ba91-7a8716f6f3d8 }}</ref>
|brandNames=* TOPICAL ANESTHETIC BANANA®<ref>{{Cite web | title =TOPICAL ANESTHETIC BANANA- benzocaine gel, dentifrice  | url =http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4fdfcaf-aa95-45a8-ba91-7a8716f6f3d8 }}</ref>


<!--Look-Alike Drug Names-->
 
|drugShortage=
|drugShortage=
}}
{{LabelImage
|fileName={{PAGENAME}}11.png
}}
{{LabelImage
|fileName={{PAGENAME}}11.png
}}
}}
}}
<!--Label Display Image-->
<!--Label Display Image-->
Line 129: Line 148:


[[Category:Drug]]
[[Category:Drug]]
[[Category:Local anesthetics]]
[[Category:Benzoates]]
[[Category:Wyeth]]

Latest revision as of 18:01, 18 August 2015

Benzocaine (topical)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Benzocaine (topical) is a local anesthetic that is FDA approved for the treatment of dental pain. Common adverse reactions include contact dermatitis.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

  • For oral mucosal use only as directed by a dentist.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Benzocaine (topical) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Benzocaine (topical) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Benzocaine (topical) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Benzocaine (topical) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Benzocaine (topical) in pediatric patients.

Contraindications

There is limited information regarding Benzocaine (topical) Contraindications in the drug label.

Warnings

There is limited information regarding Benzocaine (topical) Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Benzocaine (topical) in the drug label.

Postmarketing Experience

contact dermatitis, methemoglobinemia (rare)

Drug Interactions

There is limited information regarding Benzocaine (topical) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Benzocaine (topical) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Benzocaine (topical) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Benzocaine (topical) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Benzocaine (topical) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Benzocaine (topical) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Benzocaine (topical) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Benzocaine (topical) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Benzocaine (topical) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Benzocaine (topical) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Benzocaine (topical) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Benzocaine (topical) in patients who are immunocompromised.

Administration and Monitoring

Administration

Monitoring

There is limited information regarding Monitoring of Benzocaine (topical) in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Benzocaine (topical) in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Benzocaine (topical) in the drug label.

Pharmacology

Template:Px
Template:Px
Benzocaine (topical)
Systematic (IUPAC) name
Ethyl 4-aminobenzoate
Identifiers
CAS number 94-09-7
ATC code C05AD03 D04AB04 (WHO), Template:ATCvet, N01BA05 (WHO), R02AD01 (WHO)
PubChem 2337
DrugBank DB01086
Chemical data
Formula Template:OrganicBox atomTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox 
Mol. mass 165.189 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability ?
Metabolism ?
Half life ?
Excretion ?
Therapeutic considerations
Pregnancy cat.

C(US)

Legal status

OTC(US)

Routes Topical

Mechanism of Action

There is limited information regarding Benzocaine (topical) Mechanism of Action in the drug label.

Structure

There is limited information regarding Benzocaine (topical) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Benzocaine (topical) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Benzocaine (topical) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Benzocaine (topical) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Benzocaine (topical) in the drug label.

How Supplied

There is limited information regarding Benzocaine (topical) How Supplied in the drug label.

Storage

  • Store at controlled room temperature 59-86°F (15-30°C).

Images

Drug Images

{{#ask: Page Name::Benzocaine (topical) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

This image is provided by the National Library of Medicine.
This image is provided by the National Library of Medicine.

{{#ask: Label Page::Benzocaine (topical) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Benzocaine (topical) in the drug label.

Precautions with Alcohol

  • Alcohol-Benzocaine (topical) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

  • TOPICAL ANESTHETIC BANANA®[1]

Look-Alike Drug Names

There is limited information regarding Benzocaine (topical) Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ "TOPICAL ANESTHETIC BANANA- benzocaine gel, dentifrice".
Retrieved from "https://www.wikidoc.org/index.php?title=Benzocaine_(topical)&oldid=1134791"